HRP950217B1 - Novel erythromycin derivatives, method for preparing the same and use thereof as drugs - Google Patents

Novel erythromycin derivatives, method for preparing the same and use thereof as drugs

Info

Publication number
HRP950217B1
HRP950217B1 HR950217A HRP950217A HRP950217B1 HR P950217 B1 HRP950217 B1 HR P950217B1 HR 950217 A HR950217 A HR 950217A HR P950217 A HRP950217 A HR P950217A HR P950217 B1 HRP950217 B1 HR P950217B1
Authority
HR
Croatia
Prior art keywords
drugs
preparing
same
erythromycin derivatives
novel erythromycin
Prior art date
Application number
HR950217A
Other languages
English (en)
Inventor
Constantin Agouridas
Yannick Benedetti
Jean-Francois Chantot
Alexis Denis
Odile Le Martret
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of HRP950217A2 publication Critical patent/HRP950217A2/hr
Publication of HRP950217B1 publication Critical patent/HRP950217B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR950217A 1994-04-08 1995-04-07 Novel erythromycin derivatives, method for preparing the same and use thereof as drugs HRP950217B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (2)

Publication Number Publication Date
HRP950217A2 HRP950217A2 (en) 1997-08-31
HRP950217B1 true HRP950217B1 (en) 2004-06-30

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
HR950217A HRP950217B1 (en) 1994-04-08 1995-04-07 Novel erythromycin derivatives, method for preparing the same and use thereof as drugs

Country Status (49)

Country Link
US (2) US5656607A (no)
EP (1) EP0676409B1 (no)
JP (1) JP3000023B2 (no)
KR (1) KR100317148B1 (no)
CN (1) CN1059445C (no)
AP (1) AP587A (no)
AT (1) ATE234853T1 (no)
AU (1) AU684939B2 (no)
BG (1) BG61916B1 (no)
BR (1) BR9506147A (no)
CA (1) CA2164638C (no)
CO (1) CO4370097A1 (no)
CZ (1) CZ296005B6 (no)
DE (1) DE69529934T2 (no)
DK (1) DK0676409T3 (no)
DZ (1) DZ1869A1 (no)
EE (1) EE04498B1 (no)
ES (1) ES2189820T3 (no)
FI (1) FI111264B (no)
FR (1) FR2718450B1 (no)
GB (1) GB2288174A (no)
GE (1) GEP19991836B (no)
HR (1) HRP950217B1 (no)
HU (1) HU215396B (no)
IL (1) IL112954A (no)
IS (1) IS1865B (no)
JO (1) JO1850B1 (no)
LV (1) LV11182B (no)
MA (1) MA23501A1 (no)
MD (1) MD663G2 (no)
MY (1) MY114672A (no)
NO (1) NO308361B1 (no)
NZ (1) NZ284498A (no)
OA (1) OA10200A (no)
PE (1) PE2896A1 (no)
PL (1) PL180837B1 (no)
PT (1) PT676409E (no)
RO (1) RO115634B1 (no)
RU (1) RU2141965C1 (no)
SA (1) SA97170757A (no)
SI (1) SI0676409T1 (no)
SK (1) SK284079B6 (no)
SV (1) SV1995000018A (no)
TN (1) TNSN95026A1 (no)
TW (1) TW316908B (no)
UA (1) UA44705C2 (no)
WO (1) WO1995027720A1 (no)
YU (1) YU49221B (no)
ZA (1) ZA952059B (no)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
CA2253451A1 (en) * 1996-05-07 1997-11-13 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
WO1998009978A1 (en) * 1996-09-04 1998-03-12 Abbott Laboratories 6-o-substituted ketolides having antibacterial activity
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6421398A (en) * 1997-03-24 1998-10-20 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
AU6932098A (en) * 1997-05-09 1998-12-08 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
ID24529A (id) * 1997-06-11 2000-07-20 Pfizer Prod Inc Turunan-turunan 9-oksima eritromisin
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
AU5299499A (en) 1998-09-22 2000-04-10 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
WO2000034297A1 (en) 1998-12-10 2000-06-15 Pfizer Products Inc. Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
JP2003523938A (ja) * 1999-04-16 2003-08-12 コーサン バイオサイエンシーズ， インコーポレイテッド マクロライド系抗感染剤
US6458771B1 (en) 1999-04-16 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
EA200100983A1 (ru) * 1999-05-24 2002-10-31 Пфайзер Продактс Инк. Производные 13-метилэритромицина
AU2002316550A1 (en) * 2001-07-03 2003-01-21 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
CA2488853C (en) 2002-07-01 2016-06-28 Arkion Life Sciences Llc D/B/A/ Bio-Technical Resources Division Process and materials for production of glucosamine and n-acetylglucosamine
US7601695B2 (en) * 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
EP1618119A2 (en) * 2003-04-25 2006-01-25 Chiron Corporation Pyridyl substituted ketolide antibiotics
CN101917850B (zh) * 2007-10-25 2016-01-13 森普拉制药公司 大环内酯类抗菌剂的制备方法
WO2010048601A1 (en) 2008-10-24 2010-04-29 Cempra Pharmaceuticals, Inc. Biodefenses using triazole-containing macrolides
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
EP2475253B1 (en) 2009-09-10 2016-10-26 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and mac diseases
AU2011232627B2 (en) 2010-03-22 2016-03-17 Cempra Pharmaceuticals, Inc. Crystalline forms of a macrolide, and uses therefor
RU2608390C2 (ru) 2010-05-20 2017-01-18 Семпра Фармасьютикалз, Инк. Способы получения макролидов и кетолидов, и промежуточных соединений для их получения
JP6042334B2 (ja) 2010-09-10 2016-12-14 センプラ ファーマシューティカルズ，インコーポレイテッド 疾患治療のための水素結合形成フルオロケトライド
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
JP6675973B2 (ja) 2013-03-15 2020-04-08 センプラ ファーマシューティカルズ，インコーポレイテッド マクロライド抗菌薬を調製するための集束的な方法
KR102363621B1 (ko) 2013-04-04 2022-02-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 매크롤라이드 그리고 그의 제조방법 및 용도
CN106998685A (zh) 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
JP2018509452A (ja) 2015-03-25 2018-04-05 プレジデント アンド フェローズ オブ ハーバード カレッジ 修飾デソサミン糖をもつマクロライドおよびその使用
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
AP587A (en) 1997-04-29
YU21695A (sh) 1997-12-05
UA44705C2 (uk) 2002-03-15
NZ284498A (en) 1997-07-27
PE2896A1 (es) 1996-02-12
HU9503505D0 (en) 1996-02-28
OA10200A (fr) 1996-12-18
TW316908B (no) 1997-10-01
NO308361B1 (no) 2000-09-04
FI955913A (fi) 1995-12-08
DE69529934D1 (de) 2003-04-24
MA23501A1 (fr) 1995-12-31
FI111264B (fi) 2003-06-30
EE04498B1 (et) 2005-06-15
IS4309A (is) 1995-11-17
CZ296005B6 (cs) 2005-12-14
RO115634B1 (ro) 2000-04-28
CN1059445C (zh) 2000-12-13
GB9506856D0 (en) 1995-05-24
AP9500743A0 (en) 1995-07-31
YU49221B (sh) 2004-11-25
MD663G2 (ro) 1997-07-31
SK154695A3 (en) 1996-10-02
IL112954A0 (en) 1995-06-29
HUT73772A (en) 1996-09-30
BG61916B1 (bg) 1998-09-30
PT676409E (pt) 2003-08-29
EP0676409A1 (fr) 1995-10-11
WO1995027720A1 (fr) 1995-10-19
CO4370097A1 (es) 1996-10-07
FR2718450A1 (fr) 1995-10-13
DE69529934T2 (de) 2003-09-04
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
NO954942D0 (no) 1995-12-06
CN1126997A (zh) 1996-07-17
KR100317148B1 (ko) 2002-06-22
ATE234853T1 (de) 2003-04-15
LV11182A (lv) 1996-04-20
SK284079B6 (sk) 2004-09-08
HRP950217A2 (en) 1997-08-31
DK0676409T3 (da) 2003-06-23
CA2164638C (fr) 2003-12-30
BG100150A (bg) 1996-06-28
LV11182B (en) 1997-04-20
US5760233A (en) 1998-06-02
TNSN95026A1 (fr) 1996-02-06
MY114672A (en) 2002-12-31
AU684939B2 (en) 1998-01-08
PL180837B1 (pl) 2001-04-30
GB2288174A (en) 1995-10-11
RU2141965C1 (ru) 1999-11-27
NO954942L (no) 1996-02-07
JPH07278177A (ja) 1995-10-24
ZA952059B (en) 1996-03-13
ES2189820T3 (es) 2003-07-16
GEP19991836B (en) 1999-11-05
PL311871A1 (en) 1996-03-18
CZ322395A3 (en) 1996-08-14
IL112954A (en) 2000-07-16
FI955913A0 (fi) 1995-12-08
SI0676409T1 (en) 2003-06-30
JP3000023B2 (ja) 2000-01-17
BR9506147A (pt) 1996-04-16
EE9500080A (et) 1996-12-16
US5656607A (en) 1997-08-12
AU2310795A (en) 1995-10-30
CA2164638A1 (fr) 1995-10-19
DZ1869A1 (fr) 2002-02-17
SA97170757A (ar) 2005-12-03
HU215396B (hu) 1998-12-28
IS1865B (is) 2003-05-02
FR2718450B1 (fr) 1997-01-10
MD663F1 (ro) 1997-01-31
SV1995000018A (es) 1997-10-24

Similar Documents

Publication Publication Date Title
HRP950217B1 (en) Novel erythromycin derivatives, method for preparing the same and use thereof as drugs
HU9603038D0 (en) Novel erythromycin derivatives, method for their preparation and their use as drugs
HUP9902576A3 (en) Novel erythromycin derivatives, method for preparing them, and use thereof as drugs
HUP0001115A3 (en) Heterocyclylmethyl-substituted pyrazol derivatives, process for their preparation and pharmaceuticals containing the same
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
HUP9900974A3 (en) Heterocycle-condensed morphinoid derivatives, process for the preparation thereof, their use and pharmaceutical compositions containing them
PL348098A1 (en) Novel erythromycin derivatives, preparation method and use as medicines
EP0599159A3 (de) a-L-Rhamnosidase zur Gewinnung von Rhamnose, ein Verfahren zur Herstellung und ihre Verwendung.
HUP9600665A3 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
GB9310075D0 (en) New mercapto-amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
HUP9903424A3 (en) Novel erythromycin derivatives,method for preparing same and use thereof as drugs
HRP931016A2 (en) Thienothiazin derivatives, process for the preparation and application thereof
IL130420A (en) Erythromycin derivatives, method for preparing them and their use as medicine
GR3035834T3 (en) Benzoxazindione derivatives, process for their preparation and their use
AU3218195A (en) Alpha-d-pentofuranoside derivatives, process for preparing the same and their use
EP0775705A3 (en) Cyclopentenecarboxamide derivative, method for its preparation and bicycloamide derivative used in this method
GR3036226T3 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
HUP0103997A3 (en) Novel 6-deoxy erythromycin derivatives, method for preparing same and use as medicines
ZA9610708B (en) Oxaindene derivatives and process for the preparation thereof.
HU9701216D0 (en) New nitropyrazolester derivatives, process for their preparation and their use
SI0794184T1 (en) 6-methoxy-1h-benzotriazole-5-carboxamide derivatives, process for producing the same, and medicinal composition containing the same
SI1165596T1 (en) 14,15-alpha-methylene equilenine derivatives, methods for producing the same and medicaments containing them
EP0754665A3 (en) 3-substituted alpha-beta-dibromoethylbenzenes and process for their preparation

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ROUSSEL UCLAF, FR

Owner name: HOECHST MARION ROUSSEL, FR

Owner name: AVENTIS PHARMA S.A., FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20140311

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20150407